negative regulation of histone H3-K27 acetylation

Known as: inhibition of histone H3 acetylation at K27, downregulation of histone H3K27 acetylation, down regulation of histone H3K27 acetylation 
Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K27 acetylation. [GOC:BHF, GOC:TermGenie]
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2018
012320042018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Polycomb repressive complex 2 (PRC2) consists of three core subunits, EZH2, EED and SUZ12, and plays pivotal roles in… (More)
Is this relevant?
2016
2016
Cancer stem cells are associated with tumor recurrence. IKK is a protein kinase that is composed of IKKα, IKKβ, IKKγ. Herein, we… (More)
Is this relevant?
2014
2014
Eed (embryonic ectoderm development) is a core component of the Polycomb Repressive Complex 2 (PRC2) which catalyzes the… (More)
  • figure 1
Is this relevant?
2013
2013
Oncogenic signaling pathways regulate gene expression in part through epigenetic modification of chromatin including DNA… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Mutations at tyrosine 641 (Y641F, Y641N, Y641S and Y641H) in the SET domain of EZH2 have been identified in patients with certain… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
OBJECTIVE To study the regulatory rolesof SIRT1 on EZH2 expression and the further effects on EZH 2’ s repression of target gene… (More)
Is this relevant?
2010
2010
OBJECTIVE To study the regulatory mechanism of SATB1 repression in cells other than T cells or erythroid cells, which have high… (More)
Is this relevant?
2009
2009
Spinal and bulbar muscular atrophy (SBMA) is a neurodegenerative disorder caused by a polyglutamine repeat (polyQ) expansion… (More)
  • figure 4
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
The endemic species of Antrodia camphorate (AC) is a promising chemotherapeutic drug for cancer. We found that the ethanol… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
To understand the mechanisms of PTEN inactivation, which is reported to be involved in tumor progression and drug resistance in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?